Claritev unveils new brand identity, reinforcing its mission to transform healthcare affordability and transparency
Claritev Corporation, formerly known as MultiPlan, has announced a significant corporate rebrand, reflecting its expanded focus on healthcare affordability solutions, AI-driven healthcare, and price transparency ... Read More
Pfizer receives FDA approval for Nivestym, a Neutropenia biosimilar
Pfizer Inc. has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for Nivestym (filgrastim-aafi), a biosimilar to Amgen's Neupogen ... Read More